Georg Ott

Global Head Small Molecules Breast at Astrazeneca @AstraZeneca

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2023 — Present

Global Head Small Molecules Breast at Astrazeneca @AstraZeneca

View department →

Cambridge, GB

Leading Medical revolution to eliminate breast cancer as a cause of death by heading the global Small Molecule Breast Cancer team. Accountable for the Global Medical strategy and plans in breast cancer for endocrine therapies, therapies targeting tumor drivers and resistance (TDR) and DNA Damage Repair (DDR).2 product launches

EDUCATION

N/A

WU Executive Academy

Global Executive MBA

1995 — 2001

Technische Universität Graz

DI (MSc), Biochemistry

N/A

Carlson Executive Education, University of Minnesota

Executive MBA

2002 — 2005

Medical University of Vienna

PhD, Biomedical Sciences - Signal Transduction

SKILLS

BiochemistryProtein ExpressionAntibodiesMolecular BiologyProtein ChemistryImmunologyDrug DiscoveryIn VitroBiomarker DiscoveryMonoclonal AntibodiesOncologyClinical DevelopmentIn VivoDrug DevelopmentLaboratoryCell CultureProtein PurificationElisaCancerCellCell BiologyAssay DevelopmentMedical Affairs

ABOUT GEORG OTT

At AstraZeneca, my leadership in Global Medical Affairs for Small Molecules Breast Cancer propels our mission to eradicate breast cancer as a cause of death. By steering the strategic direction for endocrine therapies, tumor driver resistance and, DNA damage repair I contribute to the development and global launch of groundbreaking treatments. My collaborative efforts have fostered a strong evidence base that supports our innovative therapies and enhances patient outcomes.My tenure at AstraZeneca has been marked by transformative leadership within Global Medical Affairs, EU-CAN Medical Affairs and the Austrian affiliate where I have shaped the Medical and commercialization strategy for key assets. Leading medical teams through successful product launches, I\'ve ensured that our strategies resonate with healthcare providers and benefit patients. The drive for excellence in medical affairs is matched by my commitment to advancing oncology treatments and a culture of high performance and innovation.I have launched 9 innovative Medicines in multiple indications in global, regional and country roles and have shaped and led a drug compound as early product lead in R&D.My education in Oncology, Immunology and Business Administration combined with 16+ leadership experience in pharmaceutical industry make me a passionate senior leader with the passion to eliminate cancer as a cause of death.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Georg Ott — Global Head Small Molecules Breast at Astrazeneca at AstraZeneca in Cambridge, GB | Unifers